
bioAffinity Technologies, Firefly Neuroscience, BigBear.ai, JetBlue Airways, Kosmos Energy, Iovance Biotherapeutics, and iSpecimen are the seven Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are low-priced shares of small companies, typically trading for less than $5 per share and often quoted on over-the-counter markets or “pink sheets” rather than major exchanges. They tend to be thinly traded, highly volatile and subject to limited public disclosure, making them speculative and higher-risk investments prone to large losses and fraud. These companies had the highest dollar trading volume of any Penny stocks within the last several days.
bioAffinity Technologies (BIAF)
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Firefly Neuroscience (AIFF)
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.
Read Our Latest Research Report on AIFF
BigBear.ai (BBAI)
BigBear.ai Holdings, Inc. provides artificial intelligence-powered decision intelligence solutions. It offers national security, supply chain management, and digital identity and biometrics solutions. The company also provides data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics, and predictive visualization solutions and services.
Read Our Latest Research Report on BBAI
JetBlue Airways (JBLU)
JetBlue Airways Corporation provides air transportation services. The company operates a fleet of Airbus A321, Airbus A220, Airbus A321neo, Airbus A320 Restyled, Airbus A320, Airbus A321 with Mint, Airbus A321neo with Mint, Airbus A321neoLR with Mint, and Embraer E190 aircraft. It also serves 100 destinations across the United States, the Caribbean and Latin America, Canada, and Europe.
Read Our Latest Research Report on JBLU
Kosmos Energy (KOS)
Kosmos Energy Ltd., together with its subsidiaries, engages in the exploration, development, and production of oil and gas along the Atlantic Margins in the United States. The company’s primary assets include production projects located in offshore Ghana, Equatorial Guinea, and the U.S. Gulf of Mexico, as well as gas projects located in offshore Mauritania and Senegal.
Read Our Latest Research Report on KOS
Iovance Biotherapeutics (IOVA)
Iovance Biotherapeutics, Inc., a commercial-stage biotechnology company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic renal cell carcinoma.
Read Our Latest Research Report on IOVA
iSpecimen (ISPC)
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.
Read Our Latest Research Report on ISPC
Featured Articles
- MarketBeat’s Top Five Stocks to Own in March 2026
- Ollie’s Stock Won’t Stay a Bargain Much Longer
- 3 Stocks That Could Be Next to Announce a Stock Split
- U.S. Shipbuilding Revival: 3 Stocks to Watch Now
- Eli Lilly’s Employer Push Could Unlock New GLP-1 Demand
- Ulta Beauty and an Ultimate Entry: Price Resets After Profit Miss
